Literature DB >> 8536360

Relationships between humoral factors in HIV-1-infected mothers and the occurrence of HIV infection in their infants.

A Mabondzo1, P Rouvier, H Raoul, R Le Naour, C Courpotin, F Hervé, F Parnet-Mathieu, G Lasfargues, D Dormont.   

Abstract

Based on what is known about the biology of HIV-1 vertical transmission, the HIV burden of the mother, maternal immune factors and the integrity of the placental barrier are likely to play major roles. We therefore sought to determine whether the presence of antibodies in sera from 47 HIV-1-infected mothers, including 30 non-transmitting and 17 transmitting mothers, affected the risk of HIV-1 transmission to infants. Our findings showed no significant correlation between the capacity of antibodies to mediate antibody-dependent cell-mediated cytotoxicity (ADCC) and their capacity to induce protection of the child from HIV-1 infection (P = 0.14). Furthermore, no correlation was found between the capacity of maternal antibodies to neutralize in vitro lymphocyte or macrophage heterologous viral infection and the occurrence of in vivo HIV-1 infection in the infant. Sera recovered from five of 12 transmitting mothers and from five of 11 non-transmitting mothers were compared in their capacity to neutralize the viruses drawn from the same individuals. Four out of five maternal isolates from transmitting mothers and all maternal isolates from non-transmitting mothers were sensitive to enhancement of infection mediated by the maternal serum.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8536360      PMCID: PMC1553385          DOI: 10.1111/j.1365-2249.1995.tb03840.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

2.  Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals.

Authors:  J Homsy; M Meyer; J A Levy
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

3.  Detection of antibodies which mediate human immunodeficiency virus-specific cellular cytotoxicity (ADCC) in vitro.

Authors:  K Ljunggren; E M Fenyö; G Biberfeld; M Jondal
Journal:  J Immunol Methods       Date:  1987-11-23       Impact factor: 2.303

4.  Possible involvement of HIV in neuropsychiatric episode in patient seronegative for two (or more) years.

Authors:  F Boussin; D Dormont; Y Merrouche; H Fleury; D Dubeaux; D Bequet; J Goasguen; P Brunet
Journal:  Lancet       Date:  1987-09-05       Impact factor: 79.321

5.  Immunological and virological clues for mother-to-child transmission of HIV-1 and HIV-2.

Authors:  S D Douglas
Journal:  JAMA       Date:  1994-08-10       Impact factor: 56.272

6.  Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.

Authors:  A H Rook; H C Lane; T Folks; S McCoy; H Alter; A S Fauci
Journal:  J Immunol       Date:  1987-02-15       Impact factor: 5.422

7.  Antibody-dependent cellular cytotoxicity and neutralization of human immunodeficiency virus type 1 by high affinity cross-linking of gp41 to human macrophage Fc IgG receptor using bispecific antibody.

Authors:  A Mabondzo; F Boussin; H Raoul; R Le Naour; G Gras; B Vaslin; J Bartholeyns; J L Romet-Lemonne; D Dormont
Journal:  J Gen Virol       Date:  1994-06       Impact factor: 3.891

8.  Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers.

Authors:  K Ljunggren; V Moschese; P A Broliden; C Giaquinto; I Quinti; E M Fenyö; B Wahren; P Rossi; M Jondal
Journal:  J Infect Dis       Date:  1990-02       Impact factor: 5.226

9.  Variable and conserved neutralization antigens of human immunodeficiency virus.

Authors:  R A Weiss; P R Clapham; J N Weber; A G Dalgleish; L A Lasky; P W Berman
Journal:  Nature       Date:  1986 Dec 11-17       Impact factor: 49.962

10.  Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus.

Authors:  T M Folks; D Powell; M Lightfoote; S Koenig; A S Fauci; S Benn; A Rabson; D Daugherty; H E Gendelman; M D Hoggan
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

View more
  3 in total

1.  Passively acquired antibody-dependent cellular cytotoxicity (ADCC) activity in HIV-infected infants is associated with reduced mortality.

Authors:  Caitlin Milligan; Barbra A Richardson; Grace John-Stewart; Ruth Nduati; Julie Overbaugh
Journal:  Cell Host Microbe       Date:  2015-04-08       Impact factor: 21.023

2.  Maternal plasma viral load and neutralizing/enhancing antibodies in vertical transmission of HIV: a non-randomized prospective study.

Authors:  Paul Kamara; Loyda Melendez-Guerrero; Miguel Arroyo; Heidi Weiss; Pauline Jolly
Journal:  Virol J       Date:  2005-02-24       Impact factor: 4.099

3.  Maternal Neutralization-Resistant Virus Variants Do Not Predict Infant HIV Infection Risk.

Authors:  Caitlin Milligan; Maxwel M Omenda; Vrasha Chohan; Katherine Odem-Davis; Barbra A Richardson; Ruth Nduati; Julie Overbaugh
Journal:  mBio       Date:  2016-02-02       Impact factor: 7.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.